This company has shut down. Synthase Biotech is no longer operating — its last tracked round was a Grant in 2022.
Explore the Startup GraveyardSynthase Biotech aim to develop, manufacture, supply welldesigned high quality life-extension enzyme technologies for the benefit of humans.
Synthase Biotech has raised $6K in total funding. The most recent round was Grant. The last funding was announced in September 2022.
Synthase Biotech's investors include Callaghan Innovation, Enterprise Angels, Ice Angels, New Zealand Venture Investment Fund, Matū Group.
Synthase Biotech is headquartered in Hamilton, New Zealand.
Synthase Biotech aim to develop, manufacture, supply welldesigned high quality life-extension enzyme technologies for the benefit of humans.
Synthase Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synthase Biotech — Funding & Investors." VCBacked, September 15, 2022, https://www.vcbacked.co/company/synthase-biotech. Accessed August 13, 2026.
VCBacked. (2022). Synthase Biotech — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/synthase-biotech
{{cite web |title=Synthase Biotech — Funding & Investors |url=https://www.vcbacked.co/company/synthase-biotech |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated